Breast Cancer

Endocrine therapy is a valuable treatment option for women whose breast tumors express the estrogen receptor (ER). In these women, endocrine therapy can block the tumor’s ability to produce estrogen–a hormone that promotes the growth of ER+ tumors–or interfere with its actions.

The world of breast cancer management is changing, just as the statistics for the disease has improved over the past decade.

The BCI provides additional information about the individual’s risk of recurrence beyond year 5 and the likelihood of benefiting from extended therapy and may help encourage compliance in those who opt to continue.

In this review, we will reflect on tools currently available to a clinician involved in the treatment of patients with breast cancer and shed light on emerging technologies that may be utilized in the near future.

In this special breast cancer issue of JONS, we are proud to present the 12 evidence-based breast cancer research abstracts that were presented as posters at the 2017 AONN+ Annual Conference.

We ask, “How can nurse navigators better educate disparate populations about breast health and cancer screening at home and abroad?”

Communication gaps between HCPs and MBC patients must be addressed to improve the patient experience. Patients likely overestimate their knowledge about their breast cancer subtype.

Metastatic breast cancer (MBC) patients receive an overwhelming amount of information at the time of diagnosis, with most of the information transferred through oral conversations and abstract medical terminology that’s difficult for patients to understand.

The study was conducted by the nurse navigator at Sarah Cannon Cancer Institute at Research Medical Center in Kansas City, a member of the oncology service-line for HCA. Nurse navigators are exposed to many processes in the cancer care system and recognize when systems are not at optimal functioning.

Approximately 42% of breast cancer survivors develop clinically detectable lymphedema within 5 years of treatment. Early intervention and education is crucial to decrease long-term morbidity and improve patient outcomes.